Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT02227901 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

DRUG: Tipifarnib
RADIATION: External Beam Radiation Therapy
DRUG: Temozolomide
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)